Eligibility for long-acting cabotegravir/rilpivirine in youth aged 12-25 living with perinatally acquired HIV

被引：0
|
作者：
Ryan, Fionnuala [1 ]
Mackie, Nicola E. [2 ]
Jayadel, Hana [1 ]
Ayers, Sara [2 ]
Foster, Caroline [1 ,2 ]
机构：
[1] Imperial Coll Healthcare NHS Trust, Dept Paediat Infect Dis, London, England
[2] Imperial Coll Healthcare NHS Trust, Dept GUM HIV Med, London, England
来源：
HIV MEDICINE | 2023年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
O20
引用
收藏
页码：16 / 16
页数：1
相关论文
共 50 条
  • [31] Cabotegravir: a novel HIV integrase inhibitor combined with rilpivirine as the first long-acting injectable program for the treatment of HIV infection
    Zeuli, John D.
    Rivera, Christina G.
    Smith, Bradley L.
    Otto, Ashley
    Temesgen, Zelalem
    DRUGS OF TODAY, 2022, 58 (12) : 555 - 576
  • [32] Low cabotegravir trough concentrations without oral lead-in in patients with HIV-1 switching to long-acting cabotegravir and rilpivirine
    Rubenstein, Emma
    Diemer, Myriam
    Goldwirt, Lauriane
    Lascoux-Combe, Caroline
    Chaix, Marie-Laure
    Rami, Agathe
    Ponscarme, Diane
    Lafaurie, Matthieu
    Denis, Blandine
    De Castro, Nathalie
    Gras, Julien
    Liegeon, Geoffroy
    Sellier, Pierre-Olivier
    Deville, Laure
    Chevret, Sylvie
    Delaugerre, Constance
    Molina, Jean-Michel
    AIDS, 2024, 38 (08) : 1267 - 1269
  • [33] Cost-utility analysis of long-acting cabotegravir plus rilpivirine for the treatment of HIV infection in the United Kingdom
    Parker, B.
    Chounta, V.
    Gait, C.
    Hayward, O.
    Hunjan, M.
    Schroeder, M.
    Jacob, I.
    Van de Velde, N.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2020, 23 : 37 - 37
  • [34] Cabotegravir plus rilpivirine long-acting as HIV-1 maintenance therapy: ATLAS Week 96 results
    Swindells, S.
    Lutz, T.
    Van Zyl, L.
    Porteiro, N.
    Benn, P.
    Huang, J.
    Harrington, C.
    Hove, K.
    Ford, S.
    Talarico, C.
    Chounta, V.
    Crauwels, H.
    Van Solingen-Ristea, R.
    Vanveggel, S.
    Margolis, D.
    Smith, K.
    Vandermeulen, K.
    Spreen, W.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2020, 23 : 19 - 21
  • [35] Cabotegravir + Rilpivirine Long-Acting Injections for HIV Treatment in the US: Real World Data from the OPERA Cohort
    Michael G. Sension
    Laurence Brunet
    Ricky K. Hsu
    Jennifer S. Fusco
    Quateka Cochran
    Christine Uranaka
    Gayathri Sridhar
    Vani Vannappagari
    Jean Van Wyk
    Lewis McCurdy
    Michael B. Wohlfeiler
    Gregory P. Fusco
    Infectious Diseases and Therapy, 2023, 12 : 2807 - 2817
  • [36] Cabotegravir-Rilpivirine: The First Complete Long-Acting Injectable Regimen for the Treatment of HIV-1 Infection
    Durham, Spencer H.
    Chahine, Elias B.
    ANNALS OF PHARMACOTHERAPY, 2021, 55 (11) : 1397 - 1409
  • [37] Cabotegravir plus rilpivirine long-acting as HIV-1 maintenance therapy: ATLAS week 96 results
    Swindells, Susan
    Lutz, Thomas
    Van Zyl, Lelanie
    Porteiro, Norma
    Benn, Paul
    Huang, Jenny O.
    Harrington, Conn M.
    Hove, Kai
    Ford, Susan L.
    Talarico, Christine L.
    Chounta, Vasiliki
    Crauwels, Herta
    Van Solingen-Ristea, Rodica
    Vanveggel, Simon
    Margolis, David A.
    Smith, Kimberly Y.
    Vandermeulen, Kati
    Spreen, William R.
    Baum, Alexander
    INFECTION, 2021, 49 (SUPPL 1) : S7 - S8
  • [38] Long-acting cabotegravir/rilpivirine for HIV-1 treatment: real-world evaluation of barriers to implementation
    Wood, Brian R.
    Kassaye, Seble G.
    Gerstoft, Jan
    AIDS, 2023, 37 (04) : 689 - 691
  • [39] Uptake and discontinuation of the long-acting duo in the Swiss HIV Cohort Study: Preliminary analysis on cabotegravir plus rilpivirine
    Ramirez, J. J. Duran
    Kusejko, K.
    Metzner, K. J.
    Huber, M.
    Martin, Y.
    Stockle, M.
    Calmy, A.
    Decosterd, L. A.
    Cavassini, M.
    Bernasconi, E.
    Schmid, P.
    Gunthard, H. F.
    Braun, D. L.
    HIV MEDICINE, 2023, 24 : 79 - 81
  • [40] Cabotegravir and rilpivirine concentrations and HIV-1 RNA suppression in male and female genital fluids and rectal tissue in people with HIV on antiretroviral therapy with long-acting intramuscular cabotegravir plus rilpivirine
    Fernandez, Analuz
    Scevola, Sofia
    Niubo, Jordi
    Sykes, Craig
    Schauer, Amanda P.
    Piatti, Camila
    Morenilla, Sandra
    Sedo, Alicia
    Soriano, Irene
    Garcia, Benito
    Medina, Daniel
    Tiraboschi, Juan
    Saumoy, Maria
    Cottrell, Mackenzie L.
    Imaz, Arkaitz
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2024, 27 : 3 - 4
12345